CN106237203A - Treat psoriatic ointment - Google Patents
Treat psoriatic ointment Download PDFInfo
- Publication number
- CN106237203A CN106237203A CN201610919959.4A CN201610919959A CN106237203A CN 106237203 A CN106237203 A CN 106237203A CN 201610919959 A CN201610919959 A CN 201610919959A CN 106237203 A CN106237203 A CN 106237203A
- Authority
- CN
- China
- Prior art keywords
- ointment
- parts
- radix
- folium artemisiae
- artemisiae argyi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 34
- 230000001185 psoriatic effect Effects 0.000 title claims abstract description 21
- 239000003814 drug Substances 0.000 claims abstract description 29
- 239000000284 extract Substances 0.000 claims abstract description 24
- 229940079593 drug Drugs 0.000 claims abstract description 22
- 239000009636 Huang Qi Substances 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 15
- 206010043866 Tinea capitis Diseases 0.000 claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 14
- 208000009189 tinea favosa Diseases 0.000 claims abstract description 14
- 239000000758 substrate Substances 0.000 claims abstract description 13
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 229940099259 vaseline Drugs 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000001802 infusion Methods 0.000 claims description 3
- 239000012567 medical material Substances 0.000 claims description 3
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 claims description 2
- 230000006837 decompression Effects 0.000 claims description 2
- 238000005238 degreasing Methods 0.000 claims description 2
- 239000008367 deionised water Substances 0.000 claims description 2
- 229910021641 deionized water Inorganic materials 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 claims description 2
- 235000021286 stilbenes Nutrition 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 101000905241 Mus musculus Heart- and neural crest derivatives-expressed protein 1 Proteins 0.000 claims 1
- 229960000935 dehydrated alcohol Drugs 0.000 claims 1
- 238000007654 immersion Methods 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 230000001225 therapeutic effect Effects 0.000 abstract description 7
- 208000003251 Pruritus Diseases 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 230000035876 healing Effects 0.000 abstract description 3
- 206010037888 Rash pustular Diseases 0.000 abstract description 2
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 229940126678 chinese medicines Drugs 0.000 abstract description 2
- 230000007803 itching Effects 0.000 abstract description 2
- 231100000614 poison Toxicity 0.000 abstract description 2
- 208000029561 pustule Diseases 0.000 abstract description 2
- 239000003440 toxic substance Substances 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 13
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 4
- 201000004681 Psoriasis Diseases 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 238000001126 phototherapy Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 235000010894 Artemisia argyi Nutrition 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to one and treat psoriatic ointment, belong to technical field of Chinese medicines.This ointment is made up of the crude drug of following weight portion: Radix Sophorae Flavescentis 10 50 parts, Cortex Phellodendri 10 50 parts, the Radix Stemonae 10 50 parts, Fructus Cnidii 10 50 parts, favus skin 10 50 parts, Folium Artemisiae Argyi extract 1 part, Radix Astragali extractive solution 1 part, moisturizing substrate 100 300 parts；Described ointment is prepared by following method: by above-mentioned weight portion weighting raw materials, dry, pulverize after first Radix Sophorae Flavescentis, Cortex Phellodendri, the Radix Stemonae, Fructus Cnidii and favus skin being concocted, sieve to obtain crude drug powder, this crude drug powder and Folium Artemisiae Argyi extract, Radix Astragali extractive solution are extracted to obtain extracting solution again, then extracting solution and moisturizing substrate are blended makes described ointment.The psoriatic ointment for the treatment of that the present invention provides has heat-clearing and toxic substances removing, invigorate blood circulation and moisturize, dispelling wind for relieving itching effect, notable to the therapeutic effect of psoriatic, particularly pustule-type psoriatic effect highly significant, cure rate can reach 85%, and toxic and side effects is little, and short treating period, medical expense are low, control the features such as difficulty in relapse after healing.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to one and treat psoriatic ointment.
Background technology
Psoriasis is commonly called as psoriasis, is that a kind of chronic inflammatory skin is sick, and the course of disease is longer, has easy tendency of recurrence, some diseases
Example almost cannot be cured all one's life.This disease is fallen ill based on person between twenty and fifty, affects bigger on the healthy of patient and mental status.Clinical table
Now based on erythema, squama, whole body all can be fallen ill, and stretches side with scalp, extremity relatively conventional, increases the weight of the most in the winter time.Primary disease is current
There is no specific short, but not incurable disease.Suitable symptomatic treatment can control symptom.Owing to primary disease is a kind of chronic recurrence
Property disease, many patients need long-term medical, and various therapy has certain untoward reaction.Though western medicine therapy has necessarily at present
Short run effect, but exacerbation after drug withdrawal, it is impossible to thoroughly effect a radical cure.And Chinese traditional treatment psoriasis method is flexible and changeable, and
Determined curative effect, has the prolongation catabasis, the advantage that toxic and side effects is little.Therefore can develop and a kind of new may be used for treatment silver
The Chinese medicine of bits disease just seems most important.
Summary of the invention
It is an object of the invention to provide the psoriatic ointment for the treatment of that a kind of therapeutic effect is notable, toxic and side effects is little.
To achieve these goals, technical scheme is specific as follows:
The psoriatic ointment for the treatment of that the present invention provides, this ointment is made up of the crude drug of following weight portion:
Radix Sophorae Flavescentis 10-50 part, Cortex Phellodendri 10-50 part, Radix Stemonae 10-50 part, Fructus Cnidii 10-50 part, favus skin 10-50 part, Folium Artemisiae Argyi
Extract 1 part, Radix Astragali extractive solution 1 part, moisturizing substrate 100-300 part；
Described ointment is prepared by following method: by above-mentioned weight portion weighting raw materials, first by Radix Sophorae Flavescentis, Cortex Phellodendri, the Radix Stemonae, Serpentis
Machine tool and favus skin dry after concocting, pulverize, sieve to obtain crude drug powder, then by this crude drug powder and Folium Artemisiae Argyi extract, Radix Astragali extractive solution
Extract to obtain extracting solution, then extracting solution and moisturizing substrate are blended make described ointment.
In technique scheme, described ointment is made up of the crude drug of following weight parts: Radix Sophorae Flavescentis 30 parts, Cortex Phellodendri 30
Part, the Radix Stemonae 30 parts, Fructus Cnidii 30 parts, favus skin 30 parts, Folium Artemisiae Argyi extract 1 part, Radix Astragali extractive solution 1 part, moisturizing substrate 200 parts.
In technique scheme, described moisturizing substrate is vaseline.
In technique scheme, described Folium Artemisiae Argyi extract is to use following method to prepare:
With dry Folium Artemisiae Argyi medical material as raw material, add deionized water, 96 DEG C of water-bath backflow 90min after alcohol degreasing, obtain Chinese mugwort
Leaf infusion, is repeated 2 times, and is merged by the infusions of 3 times, filters, is concentrated to dryness with decompression Rotary Evaporators, obtains Folium Artemisiae Argyi and extracts
Thing, the extraction ratio of Folium Artemisiae Argyi is 20%, i.e. the ratio of medical material and extract is 5:1.
In technique scheme, described Radix Astragali extractive solution is to use following method to prepare:
With 50g Radix Astragali powder as raw material, add water 500mL, and heated and boiled is also stirred continuously, and keeps 30min, adds anhydrous
Ethanol 200mL, stirring and evenly mixing, room temperature stands 2h, and gauze and filter paper filtering, rotary evaporator are concentrated into 150mL, obtains 150mL yellow
Stilbene extracting solution, the concentration of gained Radix Astragali extractive solution effective ingredient is 0.33g/mL.
The usage treating psoriatic ointment that the present invention provides: after being cleaned up in the affected part of psoriatic, passes through
Medicine antiperspirant steams, and the ointment of the present invention is smeared affected part, then carries out package；Coordinate phototherapy 20 minutes twice daily；Wherein said
Medicine antiperspirant steam in medicine be Folium Artemisiae Argyi and Cortex Pseudolaricis.
The invention has the beneficial effects as follows:
The psoriatic ointment for the treatment of that the present invention provides is to be produced acquirement by each taste drug matching, and raw materials used medicine is few, adopts
Taking first process of preparing Chinese medicine part material medicine, then extract to obtain extracting solution with remaining crude drug, final and moisturizing substrate blends and makes described medicine
The technique of cream is prepared from.Gained ointment has heat-clearing and toxic substances removing, invigorates blood circulation and moisturizes, dispelling wind for relieving itching effect, controls psoriatic
Therapeutic effect is notable, particularly pustule-type psoriatic effect highly significant, and toxic and side effects is little.
The psoriatic ointment for the treatment of that the present invention provides, cure rate can reach 86%, and short treating period, medical expense are low, healing
After be difficult to the features such as recurrence.
Detailed description of the invention
In following embodiment, Folium Artemisiae Argyi extract used, Radix Astragali extractive solution use preceding method to prepare, and moisturizing substrate is all
Intellectual circle.
Embodiment 1
Weighting raw materials, Radix Sophorae Flavescentis 10g, Cortex Phellodendri 10g, Radix Stemonae 10g, Fructus Cnidii 10g, favus skin 10g, Folium Artemisiae Argyi extract 1g,
Radix Astragali extractive solution 1g, vaseline 100g；Dry after Radix Sophorae Flavescentis, Cortex Phellodendri, the Radix Stemonae, Fructus Cnidii and favus skin are concocted, pulverize, sieve
Crude drug powder, extracts to obtain extracting solution by this crude drug powder and Folium Artemisiae Argyi extract, Radix Astragali extractive solution, then is blended with vaseline by extracting solution
Make described ointment.
Embodiment 2
Weighting raw materials, Radix Sophorae Flavescentis 50g, Cortex Phellodendri 50g, Radix Stemonae 50g, Fructus Cnidii 50g, favus skin 50g, Folium Artemisiae Argyi extract 1g,
Radix Astragali extractive solution 1g, vaseline 300g；Dry after Radix Sophorae Flavescentis, Cortex Phellodendri, the Radix Stemonae, Fructus Cnidii and favus skin are concocted, pulverize, sieve
Crude drug powder, extracts to obtain extracting solution by this crude drug powder and Folium Artemisiae Argyi extract, Radix Astragali extractive solution, then is blended with vaseline by extracting solution
Make described ointment.
Embodiment 3
Weighting raw materials, Radix Sophorae Flavescentis 30g, Cortex Phellodendri 30g, Radix Stemonae 30g, Fructus Cnidii 30g, favus skin 30g, Folium Artemisiae Argyi extract 1g,
Radix Astragali extractive solution 1g, vaseline 200g；Dry after Radix Sophorae Flavescentis, Cortex Phellodendri, the Radix Stemonae, Fructus Cnidii and favus skin are concocted, pulverize, sieve
Crude drug powder, extracts to obtain extracting solution by this crude drug powder and Folium Artemisiae Argyi extract, Radix Astragali extractive solution, then is blended with vaseline by extracting solution
Make described ointment.
The therapeutic effect of ointment that the present invention provide is expanded on further below by way of clinical observation on the therapeutic effect experiment.
1, physical data
Collect light moderate psoriatic 140 example, patient is assigned randomly to experimental group (composite treatment group) and matched group
(placebo group), often group patient 70 example.
2, diagnostic criteria
Erythra development is relatively rapid, and skin rises red, and newborn erythra constantly occurs, squama is more, and epidermis is easily peeled, and has after stripping
Sieve-like petechia, substrate infiltration is deep, and pruritis is more apparent, often accompanies dry mouth and tougue, constipation, susceptible to lose temper due to restlessness, oliguria with reddish urine
Deng General Symptoms.
3, Therapeutic Method
Experimental group 70 example, after dipping every day, the external embodiment of the present invention 3 preparation ointment and carry out package, twice daily
Coordinate phototherapy 20 minutes；Matched group 70 example, external vaseline carry out package after common water-bath, twice daily, coordinate phototherapy 20
Minute；8 weeks courses for the treatment of, further consultation is once every two weeks, observes and record index.
4, efficacy assessment standard
Cure: skin heals completely, and pruritus is wholly absent, and skin becomes smooth flexible, and other corresponding symptoms disappear the most
Lose, recover normal person's life, the recurrence after healing can be avoided.
Effective: the erythema of skin, squama and infiltration degree are obviously improved, skin lesion area reduces, and other corresponding symptom starts
Take a turn for the better.
Invalid: all symptoms are all without taking a turn for the better.
5, therapeutic effect:
After medication 8 weeks, in experimental group 70 example patient, curing 60 examples, effective 10 examples, invalid 0 example, cure rate reaches 86%,
Total effective rate 100%.Matched group patients symptomatic be not improved.
The ointment that embodiment 1 and 2 prepares can obtain above-mentioned therapeutic effect too, states the most one by one.
Obviously, above-described embodiment is only for clearly demonstrating example, and not restriction to embodiment.Right
For those of ordinary skill in the field, can also make on the basis of the above description other multi-form change or
Variation.Here without also cannot all of embodiment be given exhaustive.And the obvious change thus extended out or
Change among still in the protection domain of the invention.
Claims (5)
1. treat psoriatic ointment for one kind, it is characterised in that this ointment is made up of the crude drug of following weight portion:
Radix Sophorae Flavescentis 10-50 part, Cortex Phellodendri 10-50 part, Radix Stemonae 10-50 part, Fructus Cnidii 10-50 part, favus skin 10-50 part, Folium Artemisiae Argyi is extracted
Thing 1 part, Radix Astragali extractive solution 1 part, moisturizing substrate 100-300 part；
Described ointment is prepared by following method: by above-mentioned weight portion weighting raw materials, first by Radix Sophorae Flavescentis, Cortex Phellodendri, the Radix Stemonae, Fructus Cnidii
Dry, pulverize after concocting with favus skin, sieve to obtain crude drug powder, then by this crude drug powder and Folium Artemisiae Argyi extract, Radix Astragali extractive solution extraction
Extracting solution, then extracting solution and moisturizing substrate blended make described ointment.
The psoriatic ointment for the treatment of the most according to claim 1, it is characterised in that described ointment is by following weight parts
Crude drug forms: Radix Sophorae Flavescentis 30 parts, Cortex Phellodendri 30 parts, the Radix Stemonae 30 parts, Fructus Cnidii 30 parts, favus skin 30 parts, Folium Artemisiae Argyi extract 1 part, yellow
Stilbene extracting solution 1 part, moisturizing substrate 200 parts.
The psoriatic ointment for the treatment of the most according to claim 1 and 2, it is characterised in that described moisturizing substrate is vaseline.
The psoriatic ointment for the treatment of the most according to claim 1 and 2, it is characterised in that described Folium Artemisiae Argyi extract is to use
Following method prepares:
With dry Folium Artemisiae Argyi medical material as raw material, add deionized water, 96 DEG C of water-bath backflow 90min after alcohol degreasing, obtain Folium Artemisiae Argyi water
Immersion, is repeated 2 times, and is merged by the infusions of 3 times, filters, is concentrated to dryness with decompression Rotary Evaporators, obtains Folium Artemisiae Argyi extract.
The psoriatic ointment for the treatment of the most according to claim 1 and 2, it is characterised in that described Radix Astragali extractive solution is to use
Following method prepares:
With 50g Radix Astragali powder as raw material, add water 500mL, and heated and boiled is also stirred continuously, and keeps 30min, adds dehydrated alcohol
200mL, stirring and evenly mixing, room temperature stands 2h, and gauze and filter paper filtering, rotary evaporator are concentrated into 150mL, obtain the 150mL Radix Astragali and carry
Taking liquid, the concentration of gained Radix Astragali extractive solution effective ingredient is 0.33g/mL.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610919959.4A CN106237203A (en) | 2016-10-21 | 2016-10-21 | Treat psoriatic ointment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610919959.4A CN106237203A (en) | 2016-10-21 | 2016-10-21 | Treat psoriatic ointment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106237203A true CN106237203A (en) | 2016-12-21 |
Family
ID=57600610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610919959.4A Pending CN106237203A (en) | 2016-10-21 | 2016-10-21 | Treat psoriatic ointment |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106237203A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107456510A (en) * | 2017-07-11 | 2017-12-12 | 于均峰 | A kind of ointment of the treatment psoriasis based on asafoetide root extract composition |
| CN111514240A (en) * | 2020-04-22 | 2020-08-11 | 王亚军 | Method for treating psoriasis |
| CN111973712A (en) * | 2020-09-16 | 2020-11-24 | 北京同春堂中医医院(普通合伙) | Traditional Chinese medicine bath composition for treating psoriasis, preparation method and application thereof |
| CN114272310A (en) * | 2022-01-04 | 2022-04-05 | 淄博市妇幼保健院 | Preparation method and device of medicine for treating psoriasis and external ointment |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1413627A (en) * | 2002-05-04 | 2003-04-30 | 付研彪 | Medicine for treating dematosis |
| CN101229266A (en) * | 2008-01-25 | 2008-07-30 | 贾进善 | Medicine for curing psoriasis |
| CN102614440A (en) * | 2012-04-27 | 2012-08-01 | 伊彩虹 | Multi-herb antibacterial liquid |
-
2016
- 2016-10-21 CN CN201610919959.4A patent/CN106237203A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1413627A (en) * | 2002-05-04 | 2003-04-30 | 付研彪 | Medicine for treating dematosis |
| CN101229266A (en) * | 2008-01-25 | 2008-07-30 | 贾进善 | Medicine for curing psoriasis |
| CN102614440A (en) * | 2012-04-27 | 2012-08-01 | 伊彩虹 | Multi-herb antibacterial liquid |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107456510A (en) * | 2017-07-11 | 2017-12-12 | 于均峰 | A kind of ointment of the treatment psoriasis based on asafoetide root extract composition |
| CN111514240A (en) * | 2020-04-22 | 2020-08-11 | 王亚军 | Method for treating psoriasis |
| CN111973712A (en) * | 2020-09-16 | 2020-11-24 | 北京同春堂中医医院(普通合伙) | Traditional Chinese medicine bath composition for treating psoriasis, preparation method and application thereof |
| CN114272310A (en) * | 2022-01-04 | 2022-04-05 | 淄博市妇幼保健院 | Preparation method and device of medicine for treating psoriasis and external ointment |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106237203A (en) | Treat psoriatic ointment | |
| CN103948800A (en) | Capsule for preventing chill after anesthesia and preparation method thereof | |
| CN103638404B (en) | A kind of detoxifying and relieving itching sterilization ointment and preparation method thereof | |
| CN108969642A (en) | A kind of Chinese medicine compound prescription external preparation that treating chronic prostatitis and its preparation process | |
| CN102861287A (en) | Chinese medicinal composition for treating damp-heat invasion blood stasis diabetic foot and preparation method thereof | |
| CN101897868B (en) | Chinese medicinal composition for treating psoriasis and preparation method thereof | |
| CN103920006B (en) | A kind of prevent anesthesia after shiver with cold pharmaceutical composition | |
| CN101912527A (en) | Medicinal preparation for curing wind chill blockage disease and preparation method thereof | |
| CN104013897B (en) | It is a kind of to treat Chinese medicine composition of dysmenorrhoea and preparation method thereof | |
| CN105213584A (en) | A kind of Chinese medicine composition for the treatment of eczema and preparation method thereof | |
| CN108245602A (en) | It is a kind of to treat dermopathic external medicine composition | |
| CN105055967B (en) | A kind of complex health care product and preparation method with auxiliary hyperglycemic function | |
| CN103768408B (en) | A kind of medicine preventing and treating anal and intestinal disease postoperative pain | |
| CN101884737B (en) | Chinese medicinal composition for treating hemiparalysis | |
| CN105687432A (en) | Application of traditional Chinese medicine composition in preparation of medicines for treating eczema | |
| CN102784376B (en) | Preparation method of traditional Chinese medicine for treating anorexia type acute glomerulonephritis | |
| CN101869596A (en) | Chinese medicament kudzu-vine root for preventing and treating vascular restenosis | |
| CN105582280A (en) | Traditional Chinese medicine preparation for treating angina pectoris of coronary heart disease | |
| CN105412322A (en) | Traditional Chinese medicine preparation for treating diabetic peripheral neuropathic pain and preparation method thereof | |
| CN104721290B (en) | One kind preventing and treating foot affliction bubble pin preparation and preparation method thereof | |
| CN103751489A (en) | Postoperative medicament for neurosurgery and preparation method for postoperative medicament | |
| CN105213685A (en) | A kind of Chinese medicinal ointment for the treatment of burn, diabetic foot | |
| CN103751488A (en) | Medicine for treating high-sensitivity condition after neurosurgery operation | |
| CN103735868B (en) | A kind of preparation method of anal and intestinal disease postoperative bag | |
| CN116270949A (en) | Traditional Chinese medicine composition for reducing hyperuricemia and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161221 |